vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $22.7M, roughly 2.0× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -19.9%, a 20.7% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 22.9%). R F INDUSTRIES LTD produced more free cash flow last quarter ($2.0M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 29.8%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
ABCL vs RFIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $22.7M |
| Net Profit | $-8.9M | $173.0K |
| Gross Margin | — | 36.8% |
| Operating Margin | -63.7% | 4.0% |
| Net Margin | -19.9% | 0.8% |
| Revenue YoY | 788.4% | 22.9% |
| Net Profit YoY | 73.9% | 172.7% |
| EPS (diluted) | $-0.03 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $22.7M | ||
| Q3 25 | $9.0M | $19.8M | ||
| Q2 25 | $17.1M | $18.9M | ||
| Q1 25 | $4.2M | $19.2M | ||
| Q4 24 | $5.0M | $18.5M | ||
| Q3 24 | $6.5M | $16.8M | ||
| Q2 24 | $7.3M | $16.1M | ||
| Q1 24 | $10.0M | $13.5M |
| Q4 25 | $-8.9M | $173.0K | ||
| Q3 25 | $-57.1M | $392.0K | ||
| Q2 25 | $-34.7M | $-245.0K | ||
| Q1 25 | $-45.6M | $-245.0K | ||
| Q4 24 | — | $-238.0K | ||
| Q3 24 | $-51.1M | $-705.0K | ||
| Q2 24 | $-36.9M | $-4.3M | ||
| Q1 24 | $-40.6M | $-1.4M |
| Q4 25 | — | 36.8% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 29.8% | ||
| Q4 24 | — | 31.3% | ||
| Q3 24 | — | 29.5% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | 24.5% |
| Q4 25 | -63.7% | 4.0% | ||
| Q3 25 | -851.8% | 3.6% | ||
| Q2 25 | -290.2% | 0.6% | ||
| Q1 25 | -1479.6% | 0.3% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | -1439.4% | -2.5% | ||
| Q2 24 | -1276.2% | -2.6% | ||
| Q1 24 | -551.5% | -15.5% |
| Q4 25 | -19.9% | 0.8% | ||
| Q3 25 | -637.8% | 2.0% | ||
| Q2 25 | -203.3% | -1.3% | ||
| Q1 25 | -1077.2% | -1.3% | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | -785.4% | -4.2% | ||
| Q2 24 | -504.3% | -26.7% | ||
| Q1 24 | -408.0% | -10.1% |
| Q4 25 | $-0.03 | $0.01 | ||
| Q3 25 | $-0.19 | $0.04 | ||
| Q2 25 | $-0.12 | $-0.02 | ||
| Q1 25 | $-0.15 | $-0.02 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $-0.17 | $-0.07 | ||
| Q2 24 | $-0.13 | $-0.41 | ||
| Q1 24 | $-0.14 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $35.2M |
| Total Assets | $1.4B | $73.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $5.1M | ||
| Q3 25 | $83.2M | $3.0M | ||
| Q2 25 | $92.4M | $3.6M | ||
| Q1 25 | $159.3M | $1.3M | ||
| Q4 24 | $156.3M | $839.0K | ||
| Q3 24 | $126.6M | $1.8M | ||
| Q2 24 | $148.3M | $1.4M | ||
| Q1 24 | $123.6M | $4.5M |
| Q4 25 | $966.9M | $35.2M | ||
| Q3 25 | $964.0M | $34.8M | ||
| Q2 25 | $1.0B | $34.2M | ||
| Q1 25 | $1.0B | $34.2M | ||
| Q4 24 | $1.1B | $34.1M | ||
| Q3 24 | $1.1B | $34.1M | ||
| Q2 24 | $1.1B | $34.6M | ||
| Q1 24 | $1.1B | $38.7M |
| Q4 25 | $1.4B | $73.0M | ||
| Q3 25 | $1.4B | $73.2M | ||
| Q2 25 | $1.4B | $72.7M | ||
| Q1 25 | $1.3B | $70.4M | ||
| Q4 24 | $1.4B | $71.0M | ||
| Q3 24 | $1.4B | $71.9M | ||
| Q2 24 | $1.4B | $72.8M | ||
| Q1 24 | $1.5B | $79.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $2.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $2.0M |
| FCF MarginFCF / Revenue | -99.4% | 9.0% |
| Capex IntensityCapex / Revenue | 21.9% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 12.13× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $2.1M | ||
| Q3 25 | $-52.6M | $-311.0K | ||
| Q2 25 | $-32.4M | $2.2M | ||
| Q1 25 | $-11.6M | $601.0K | ||
| Q4 24 | $-108.6M | $-244.0K | ||
| Q3 24 | $-28.9M | $2.4M | ||
| Q2 24 | $-30.0M | $197.0K | ||
| Q1 24 | $-41.7M | $840.0K |
| Q4 25 | $-44.6M | $2.0M | ||
| Q3 25 | $-61.5M | $-419.0K | ||
| Q2 25 | $-45.8M | $2.2M | ||
| Q1 25 | $-22.2M | $574.0K | ||
| Q4 24 | $-187.0M | $-418.0K | ||
| Q3 24 | $-47.4M | $2.1M | ||
| Q2 24 | $-50.1M | $28.0K | ||
| Q1 24 | $-65.8M | $697.0K |
| Q4 25 | -99.4% | 9.0% | ||
| Q3 25 | -687.0% | -2.1% | ||
| Q2 25 | -267.9% | 11.4% | ||
| Q1 25 | -524.0% | 3.0% | ||
| Q4 24 | -3702.8% | -2.3% | ||
| Q3 24 | -728.4% | 12.6% | ||
| Q2 24 | -683.8% | 0.2% | ||
| Q1 24 | -661.5% | 5.2% |
| Q4 25 | 21.9% | 0.3% | ||
| Q3 25 | 99.7% | 0.5% | ||
| Q2 25 | 78.2% | 0.2% | ||
| Q1 25 | 251.1% | 0.1% | ||
| Q4 24 | 1552.7% | 0.9% | ||
| Q3 24 | 284.6% | 1.5% | ||
| Q2 24 | 274.6% | 1.0% | ||
| Q1 24 | 242.5% | 1.1% |
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
